Deutsche Boerse


Good Q3 21 figures only slightly above consensus

20/10/21 -"• Net revenues increased by 18% to €838m for Q3 21 compared to Q3 20 • EBITDA rose by 25% to €500m for Q3 21 compared to Q3 20 • Net profit attributable to shareholders increased by 32% to €300m ..."

Pages
54
Language
English
Published on
20/10/21
You may also be interested by these reports :
19/04/24
Pluxee has released its first HY results post the IPO. The recurring financial indicators were stronger than anticipated, while the net profit ...

19/04/24
Investor has delivered a remarkable start to the year through impressive performances in all segments, driving a 10% increase in its NAV – ...

18/04/24
EdenRed’s Q1 2024 update was ahead of the consensus and our estimates. Organic growth increased by 16.9% on a lfl basis, driven by growth across all ...

18/04/24
Kinnevik released lacklustre results as its growth-oriented portfolio continued to suffer in this high interest rate environment. However, the new ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO